Abstract

There is a lack of guidelines for physical exercise in patients with myasthenia gravis (MG). A few pilot studies have shown that exercise can be safely applied to patients with MG. However, how physical exercise affects body composition, disease function, and disease severity remains unknown. In this prospective study, we enrolled 34 patients with MG with stable condition and evaluated the disease severity, physical fitness parameters, and body composition (measured using whole-body dual-energy X-ray absorptiometry (DXA)), before and after conducting a 24-week physical exercise regimen of aerobic and resistance strength training. The outcomes were measured by DXA, quantitative MG (QMG) score, quality of life score, handgrip strength and walking speed. During the training regimen, participants were free to decide how many exercise sessions per week and regularly reported their weekly exercise time. The physical exercise program was well tolerated by the participants, the parameters of the QMG score and handgrip strength improved, and participants’ body composition did not change significantly. The high exercise group experienced greater deterioration in muscle mass in the arms, but exhibited a greater improvement in forced vital capacity, walking speed, and symptom severity. The group with low QMG scores improved more in terms of physical fitness, including walking speed. These findings indicate that physical exercise is well tolerated by patients with MG, and is accompanied by improved muscular and physical functions. We propose that physical exercise is safe, effective, and appropriate for patients with well-regulated MG.

Highlights

  • Myasthenia gravis (MG) is an autoimmune disorder that can cause muscle weakness [1]

  • We evaluated the physical fitness and body composition changes in patients with MG after resistance training with different intensities of exercise and disease severities

  • We observed that physical exercise is feasible for most patients with MG and our training program was well tolerated

Read more

Summary

Introduction

Fluctuating muscle weakness is the cardinal manifestation, which can take the form of ptosis, diplopia, dysphagia, dyspnea, or limb weakness. These vary over time and can lead to exercise intolerance. Current treatment for MG includes symptomatic treatment with anticholinergic medication along with immunosuppressants and thymectomy [3,4]. These treatment strategies are effective for improving muscle strength and survival rates. These medications are well recognized to provide good symptom management, they have several side effects. Patients may be unable to return to pre-morbid level of function

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call